EPM2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.599600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.017200E-01
Normal-vs-Stage2
2.430300E-02
Normal-vs-Stage3
3.414200E-02
Normal-vs-Stage4
8.613600E-02
Stage1-vs-Stage2
2.131600E-01
Stage1-vs-Stage3
7.047600E-02
Stage1-vs-Stage4
2.676200E-01
Stage2-vs-Stage3
2.929000E-01
Stage2-vs-Stage4
8.453600E-01
Stage3-vs-Stage4
2.351800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.367900E-02
Normal-vs-AfricanAmerican
1.095240E-01
Normal-vs-Asian
8.399800E-02
Caucasian-vs-AfricanAmerican
7.081000E-01
Caucasian-vs-Asian
6.740800E-01
AfricanAmerican-vs-Asian
5.323600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.945900E-02
Normal-vs-Female
6.828100E-02
Male-vs-Female
4.511000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.004200E-01
Normal-vs-Age(41-60Yrs)
3.226200E-02
Normal-vs-Age(61-80Yrs)
7.600000E-02
Normal-vs-Age(81-100Yrs)
1.218350E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.867200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.411400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.259600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.196000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.601200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.044200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.753620E-01
Normal-vs-Daily Drinker
1.603450E-01
Normal-vs-Weekly Drinker
4.940200E-02
Normal-vs-Occasional Drinker
1.841600E-01
Normal-vs-Social Drinker
5.002200E-01
Non Drinker-vs-Daily Drinker
5.762200E-01
Non Drinker-vs-Weekly Drinker
5.730800E-01
Non Drinker-vs-Occasional Drinker
3.517400E-01
Non Drinker-vs-Social Drinker
1.867620E-01
Daily Drinker-vs-Weekly Drinker
3.782800E-01
Daily Drinker-vs-Occasional Drinker
2.381000E-01
Daily Drinker-vs-Social Drinker
1.389390E-01
Weekly Drinker-vs-Occasional Drinker
6.970000E-01
Weekly Drinker-vs-Social Drinker
3.398200E-01
Occasional Drinker-vs-Social Drinker
5.214800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.132200E-01
Normal-vs-Grade 2
5.094800E-01
Normal-vs-Grade 3
5.729200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.117590E-01
Grade 1-vs-Grade 3
2.371900E-02
Grade 1-vs-Grade 4
4.132200E-01
Grade 2-vs-Grade 3
1.086960E-01
Grade 2-vs-Grade 4
5.094800E-01
Grade 3-vs-Grade 4
5.729200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.280580E-01
Normal-vs-NonDiabetic
2.911900E-02
Diabetic-vs-NonDiabetic
6.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.502800E-01
Normal-vs-NoPancreatitis
2.609500E-02
Pancreatitis-vs-NoPancreatitis
8.677400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.502500E-02
Normal-vs-N1
2.202200E-02
N0-vs-N1
1.745230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.199970E-02
Normal-vs-TP53-NonMutant
3.138600E-01
TP53-Mutant-vs-TP53-NonMutant
2.032200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
